[ad_1] TAMPERE, Finland, Sept. 20, 2024 /PRNewswire/ — The following persons have been appointed to Bioretec’s Shareholders’ Nomination Board: Kustaa Poutiainen, Chair and Founder of Stephen Industries Inc Oy as Chair and Karoliina Lindroos, Head of Responsible Investment of […]
Tag: Medical Pharmaceuticals
Bioretec’s Shareholders’ Nomination Board appointed
[ad_1] TAMPERE, Finland, Sept. 20, 2024 /PRNewswire/ — The following persons have been appointed to Bioretec’s Shareholders’ Nomination Board: Kustaa Poutiainen, Chair and Founder of Stephen Industries Inc Oy as Chair and Karoliina Lindroos, Head of Responsible Investment of […]
RYBREVANT® (amivantamab-vmjw) plus standard of care approved in the U.S. as first and only targeted regimen to cut risk of disease progression by more than half in second-line EGFR-mutated advanced lung cancer
[ad_1] Approval based on compelling safety and efficacy from the Phase 3 MARIPOSA-2 study, marking the third new indication for RYBREVANT® this year, with four indications overall RARITAN, N.J., Sept. 17, 2024 /PRNewswire/ — Johnson […]
Seegene rozszerza swoją ofertę produktów dotyczących choroby mpox w wersji RUO o testy o zwiększonym wykrywaniu dla kladu 1
[ad_1] Firma wprowadza test Novaplex™ MPXV/OPXV (RUO – wyłącznie do badań naukowych) zaprojektowany do wykrywania kladu 1 wirusa, który cechuje się wyższą zakaźnością i śmiertelnością niż klad 2. Produkt jest zgodny z wydanymi przez WHO […]
Seegene élargit sa gamme de tests mpox à usage exclusif pour la recherche (RUO) avec des détections améliorées pour le clade 1
[ad_1] Lancement du test Novaplex™ MPXV/OPXV plus Assay (RUO) conçu pour détecter le clade I, dont les taux de transmission et de mortalité sont plus élevés que ceux du clade II. Le test est conforme aux profils […]
